Morphological and molecular profiles and pathways in bladder neoplasms

Antonio Lopez-Beltran, Liang Cheng, Roberta Mazzucchelli, Maristella Bianconi, Ana Blanca, Marina Scarpelli, Rodolfo Montironi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

After several decades of use of the Wealth Health Organization (WHO) 1973 grading system for bladder neoplasms (1973 WHO), a new grading system was adopted in 2004 by the WHO (2004 WHO). Some leading experts in the field of urogenital pathology have expressed their concerns with the 2004 WHO categorization system, both with regard to the nomenclature and the grading categories used. Several molecular and genetic studies have provided another perspective on the classification of urothelial neoplasms. The two most important developments are the identification of a mutation in the fibroblast growth factor receptor 3 gene in more than 50% of urothelial carcinomas and the discovery of cDNA profiles characteristic of different subsets of bladder cancer. There is strong correlation between the molecular findings and the 2004 WHO classification and prognosis.

Original languageEnglish
Pages (from-to)2893-2900
Number of pages8
JournalAnticancer Research
Volume28
Issue number5 B
StatePublished - Sep 2008

Fingerprint

Urinary Bladder Neoplasms
Organizations
Health
Receptor, Fibroblast Growth Factor, Type 3
Terminology
Molecular Biology
Complementary DNA
Pathology
Carcinoma
Mutation
Genes
Neoplasms

Keywords

  • Bladder neoplasm classification
  • Bladder neoplasms
  • Molecular classification
  • Profiling
  • Review

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lopez-Beltran, A., Cheng, L., Mazzucchelli, R., Bianconi, M., Blanca, A., Scarpelli, M., & Montironi, R. (2008). Morphological and molecular profiles and pathways in bladder neoplasms. Anticancer Research, 28(5 B), 2893-2900.

Morphological and molecular profiles and pathways in bladder neoplasms. / Lopez-Beltran, Antonio; Cheng, Liang; Mazzucchelli, Roberta; Bianconi, Maristella; Blanca, Ana; Scarpelli, Marina; Montironi, Rodolfo.

In: Anticancer Research, Vol. 28, No. 5 B, 09.2008, p. 2893-2900.

Research output: Contribution to journalArticle

Lopez-Beltran, A, Cheng, L, Mazzucchelli, R, Bianconi, M, Blanca, A, Scarpelli, M & Montironi, R 2008, 'Morphological and molecular profiles and pathways in bladder neoplasms', Anticancer Research, vol. 28, no. 5 B, pp. 2893-2900.
Lopez-Beltran A, Cheng L, Mazzucchelli R, Bianconi M, Blanca A, Scarpelli M et al. Morphological and molecular profiles and pathways in bladder neoplasms. Anticancer Research. 2008 Sep;28(5 B):2893-2900.
Lopez-Beltran, Antonio ; Cheng, Liang ; Mazzucchelli, Roberta ; Bianconi, Maristella ; Blanca, Ana ; Scarpelli, Marina ; Montironi, Rodolfo. / Morphological and molecular profiles and pathways in bladder neoplasms. In: Anticancer Research. 2008 ; Vol. 28, No. 5 B. pp. 2893-2900.
@article{9e411ea050cb49c69ac163d7394d2d49,
title = "Morphological and molecular profiles and pathways in bladder neoplasms",
abstract = "After several decades of use of the Wealth Health Organization (WHO) 1973 grading system for bladder neoplasms (1973 WHO), a new grading system was adopted in 2004 by the WHO (2004 WHO). Some leading experts in the field of urogenital pathology have expressed their concerns with the 2004 WHO categorization system, both with regard to the nomenclature and the grading categories used. Several molecular and genetic studies have provided another perspective on the classification of urothelial neoplasms. The two most important developments are the identification of a mutation in the fibroblast growth factor receptor 3 gene in more than 50{\%} of urothelial carcinomas and the discovery of cDNA profiles characteristic of different subsets of bladder cancer. There is strong correlation between the molecular findings and the 2004 WHO classification and prognosis.",
keywords = "Bladder neoplasm classification, Bladder neoplasms, Molecular classification, Profiling, Review",
author = "Antonio Lopez-Beltran and Liang Cheng and Roberta Mazzucchelli and Maristella Bianconi and Ana Blanca and Marina Scarpelli and Rodolfo Montironi",
year = "2008",
month = "9",
language = "English",
volume = "28",
pages = "2893--2900",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "5 B",

}

TY - JOUR

T1 - Morphological and molecular profiles and pathways in bladder neoplasms

AU - Lopez-Beltran, Antonio

AU - Cheng, Liang

AU - Mazzucchelli, Roberta

AU - Bianconi, Maristella

AU - Blanca, Ana

AU - Scarpelli, Marina

AU - Montironi, Rodolfo

PY - 2008/9

Y1 - 2008/9

N2 - After several decades of use of the Wealth Health Organization (WHO) 1973 grading system for bladder neoplasms (1973 WHO), a new grading system was adopted in 2004 by the WHO (2004 WHO). Some leading experts in the field of urogenital pathology have expressed their concerns with the 2004 WHO categorization system, both with regard to the nomenclature and the grading categories used. Several molecular and genetic studies have provided another perspective on the classification of urothelial neoplasms. The two most important developments are the identification of a mutation in the fibroblast growth factor receptor 3 gene in more than 50% of urothelial carcinomas and the discovery of cDNA profiles characteristic of different subsets of bladder cancer. There is strong correlation between the molecular findings and the 2004 WHO classification and prognosis.

AB - After several decades of use of the Wealth Health Organization (WHO) 1973 grading system for bladder neoplasms (1973 WHO), a new grading system was adopted in 2004 by the WHO (2004 WHO). Some leading experts in the field of urogenital pathology have expressed their concerns with the 2004 WHO categorization system, both with regard to the nomenclature and the grading categories used. Several molecular and genetic studies have provided another perspective on the classification of urothelial neoplasms. The two most important developments are the identification of a mutation in the fibroblast growth factor receptor 3 gene in more than 50% of urothelial carcinomas and the discovery of cDNA profiles characteristic of different subsets of bladder cancer. There is strong correlation between the molecular findings and the 2004 WHO classification and prognosis.

KW - Bladder neoplasm classification

KW - Bladder neoplasms

KW - Molecular classification

KW - Profiling

KW - Review

UR - http://www.scopus.com/inward/record.url?scp=53749107225&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53749107225&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 2893

EP - 2900

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 5 B

ER -